Table 3 Comparison of clinicopathologic characteristics and ADC value between T2WI scores in transition zone prostate cancer
From: In prostatic transition zone lesions (PI-RADS v2.1): which subgroup should be biopsied?
T2WI score 2 (n = 12) | T2WI score 3 (n = 47) | T2WI score 4 (n = 7) | T2WI score 5 (n = 12) | ||||
|---|---|---|---|---|---|---|---|
DWI 1, 2, 3 | DWI 1, 2, 3 | DWI 4 | DWI 5 | DWI 1, 2, 3 | DWI 4 | DWI 5 | |
Modified PI-RADS category | Category 2 | Category 3A | Category 3B | Category 4 | Category 4 | Category 4 | Category 5 |
Lesion number | 12 | 34 | 10 | 3 | 1 | 6 | 12 |
Characteristics | |||||||
Benign | 12 | 31 | 0 | 0 | 0 | 0 | 0 |
Malignant | 0 | 3 | 10 | 3 | 1 | 6 | 12 |
Extracapsular extension | |||||||
Positive | 0 | 0 | 2 | 3 | 0 | 1 | 11 |
Negative | 12 | 34 | 8 | 0 | 1 | 5 | 1 |
Gleason score | |||||||
6 | 0 | 1 | 0 | 0 | 0 | 0 | 0 |
7 | 0 | 2 | 10 | 3 | 0 | 5 | 9 |
8-9 | 0 | 0 | 0 | 0 | 1 | 1 | 3 |
ADC value | 1.147 ± 0.140 | 1.098 ± 0.146 | 0.934 ± 0.158 | 0.821 ± 0.091 | 1.001 | 0.874 ± 0.126 | 0.697 ± 0.122 |